According to recent analysis by Intel Market Research, the global generic drugs market was valued at USD 244.02 billion in 2024, with projections reaching USD 376.08 billion by 2032, reflecting a steady CAGR of 5.7% from 2025 through 2032. This expansion trajectory underscores generic medications' pivotal role in global healthcare affordability, particularly as governments worldwide...